中华神经科杂志
中華神經科雜誌
중화신경과잡지
Chinese Journal of Neurology
2014年
7期
455-459
,共5页
白青科%赵振国%隋海晶%谢秀海%陈娟%杨娟%周媛
白青科%趙振國%隋海晶%謝秀海%陳娟%楊娟%週媛
백청과%조진국%수해정%사수해%진연%양연%주원
脑缺血%卒中%血栓溶解疗法%组织型纤溶酶原激活物%磁共振成像
腦缺血%卒中%血栓溶解療法%組織型纖溶酶原激活物%磁共振成像
뇌결혈%졸중%혈전용해요법%조직형섬용매원격활물%자공진성상
Brain ischemia%Stroke%Thrombolytic therapy%Tissue plasminogen activator%Magnetic resonance imaging
目的 探讨磁共振成像(MRI)快速评价指导的觉醒型缺血性卒中(wake-up ischemic strokes,WUIS)患者静脉溶栓治疗的应用价值.方法 通过对WUIS患者和发病12 h内卒中患者行CT平扫初筛后排除颅内出血,行MR快速成像序列检查,筛选符合超急性期缺血性卒中患者,即DWI呈高信号,而T2WI或液体衰减反转恢复序列(FLAIR)无高信号改变及T1WI无低信号改变者,行重组组织型纤溶酶原激活剂(rt-PA)静脉溶栓治疗,对WUIS患者组和发病12 h卒中患者组进行临床、影像对照研究及90 d改良Rankin评分(modified Rankin scale,mRS)和生活质量Barthal指数(Barthal index,BI)比较.结果 463例被纳入本研究并进行MRI快速评价,其中261例(261/463,56.4%)通过MRI界定为超急性期缺血性卒中(WUIS组73例,73/121 =60.3%;12 h组188例,188/342=55.0%).192例(WUIS组53例和12 h组139例)进行溶栓治疗,两组基线资料及溶栓后出血转化和病死率差异无统计学意义(P均>0.05),90 d mRS评分及生活质量BI差异无统计学意义(x2=1.296、1.473,P=0.538、0.489).结论 对MRI快速评价指导的WUIS患者行静脉溶栓治疗是一种安全、有效的治疗方法.
目的 探討磁共振成像(MRI)快速評價指導的覺醒型缺血性卒中(wake-up ischemic strokes,WUIS)患者靜脈溶栓治療的應用價值.方法 通過對WUIS患者和髮病12 h內卒中患者行CT平掃初篩後排除顱內齣血,行MR快速成像序列檢查,篩選符閤超急性期缺血性卒中患者,即DWI呈高信號,而T2WI或液體衰減反轉恢複序列(FLAIR)無高信號改變及T1WI無低信號改變者,行重組組織型纖溶酶原激活劑(rt-PA)靜脈溶栓治療,對WUIS患者組和髮病12 h卒中患者組進行臨床、影像對照研究及90 d改良Rankin評分(modified Rankin scale,mRS)和生活質量Barthal指數(Barthal index,BI)比較.結果 463例被納入本研究併進行MRI快速評價,其中261例(261/463,56.4%)通過MRI界定為超急性期缺血性卒中(WUIS組73例,73/121 =60.3%;12 h組188例,188/342=55.0%).192例(WUIS組53例和12 h組139例)進行溶栓治療,兩組基線資料及溶栓後齣血轉化和病死率差異無統計學意義(P均>0.05),90 d mRS評分及生活質量BI差異無統計學意義(x2=1.296、1.473,P=0.538、0.489).結論 對MRI快速評價指導的WUIS患者行靜脈溶栓治療是一種安全、有效的治療方法.
목적 탐토자공진성상(MRI)쾌속평개지도적각성형결혈성졸중(wake-up ischemic strokes,WUIS)환자정맥용전치료적응용개치.방법 통과대WUIS환자화발병12 h내졸중환자행CT평소초사후배제로내출혈,행MR쾌속성상서렬검사,사선부합초급성기결혈성졸중환자,즉DWI정고신호,이T2WI혹액체쇠감반전회복서렬(FLAIR)무고신호개변급T1WI무저신호개변자,행중조조직형섬용매원격활제(rt-PA)정맥용전치료,대WUIS환자조화발병12 h졸중환자조진행림상、영상대조연구급90 d개량Rankin평분(modified Rankin scale,mRS)화생활질량Barthal지수(Barthal index,BI)비교.결과 463례피납입본연구병진행MRI쾌속평개,기중261례(261/463,56.4%)통과MRI계정위초급성기결혈성졸중(WUIS조73례,73/121 =60.3%;12 h조188례,188/342=55.0%).192례(WUIS조53례화12 h조139례)진행용전치료,량조기선자료급용전후출혈전화화병사솔차이무통계학의의(P균>0.05),90 d mRS평분급생활질량BI차이무통계학의의(x2=1.296、1.473,P=0.538、0.489).결론 대MRI쾌속평개지도적WUIS환자행정맥용전치료시일충안전、유효적치료방법.
Objective To investigate the value of magnetic resonance imaging (MRI)-based intravenous thrombolysis in patients with wake-up ischemic strokes (WUIS).Methods Patients presenting within 12 hours of acute stroke symptom onset and those with WUIS confirmed by CT,excluding intracranial hemorrhage,were encouraged to perform an emergent brain MRI scan to confirm the diagnosis of hyperacute ischemic stroke (hyper-intense in DWI without hyper-intense change in T2WI or fluid attenuated inversion recovery (FLAIR)).These patients then received intravenous thrombolytic therapy with recombinant tissue plasminogen activator (rt-PA).All patients were divided into either stroke presenting within 12 hours or WUIS.The clinical outcomes were assessed by the modified Rankin scale (mRS) and the Barthal index (BI) at baseline and at 90 days after the thrombolysis therapy.Results Two hundred and sixty-one patients (261/563,56.4%) had confirmed diagnosis of hyperacute ischemic stroke (WUIS,n =73,73/121 =60.3% vs within 12 hours,n =188,188/342 =55.0%).Altogether,192 patients (139 in within 12 hours group,and 53 in WUIS group) received intravenous thrombolytic therapy with rt-PA.No significant differences were found between the 2 groups at the baseline characteristics and at 90 days outcomes after the thrombolysis therapy(x2 =1.296 and 1.473,P =0.538 and 0.489,respectively).Also no significant differences were found in the incidence rate of secondary hemorrhage (including both of asymptomatic and symptomatic) and mortality rate between the 2 groups.Conclusion MRI-based intravenous thrombolysis is safe and effective in the treatment of patients with hyperacute WUIS.